top of page
covid particle.png
COVID-19 in Older People
The effect of frailty on survival in patients with COVID-19: a multicentre, European, observational cohort
covid particle.png

Chief Investigator: Jonathan Hewitt, Consultant Geriatrician Ysbyty Ystrad Fawr

Co-Chief Investigator: Kathryn McCarthy, Consultant General Surgeon, Southmead Hospital

Sponsor: Cardiff University 

Funding: None

Background and Aims

COVID-19 has proven to be one of the biggest hazards to health care systems around the world. Frailty has been used in the clinical decision making for COVID-19, yet the prevalence and effect of frailty in people with COVID-19 is unknown.

The COVID-19 in Older Persons (COPE) study is an international observational cohort study with centres in the UK and Italy. The main aims are to establish the prevalence of frailty and its effect on clinically important outcomes such as length of stay and mortality in patients with COVID-19.

HRA Approval can be found here


Centres included in the COPE study so far are:


  1. Aneurin Bevan Health Board (Ysbyty Ystrad Fawr, Royal Gwent and Nevill Hall)

    • Jonathan Hewitt

    • Charlotte Davey​

    • Sheila Jones

    • Kiah Lunstone

    • Alice Cavenagh

    • Charlotte Silver

    • Thomas Telford

    • Rebecca Simmons

  2. Southmead Hospital (Bristol)

    • Kathryn McCarthy

    • Tarik El Jichi Mutasem​

    • Sandeep Singh

    • Dolcie Paxton

    • Will Harris

  3. Aberdeen Royal Infirmary (Aberdeen)

  4. Royal Alexandra Hospital (Paisley)

    • Susan Moug

    • Norman Glabraith​

    • Emma Bhatti

    • Jenny Edwards

    • Siobhan Duffy

  5. Royal Inverclyde Hospital (Inverclyde)

  6. Salford Royal Hospital (Salford)

  7. Glasgow Royal Infirmary (Glasgow)

  8. University Hospital of Wales (Cardiff)

    • Michael Stechman

  9. Ysbyty Gwynedd (Bangor)

    • Louis Evans


  1. University Hospital of Modena

    • Alessia Verduri


Results of the study are pending and links to the publication will be posted shortly.

bottom of page